Christine S. Muli

Also affiliated with Purdue University West Lafayette, National Cancer Institute, Center for Cancer Research

Biochemistry, Genetics and Molecular BiologyMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers”.

Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers

Bioorganic & Medicinal Chemistry Letters(2023)10.1016/j.bmcl.2023.129485

N/A

0.373DataRank · unranked

11 citations

Christine S. Muli, Eslam M.H. Ali, Dan Xie, Mostafa H. Ahmed, Carol Beth Post +2 more

Optimized isolation of enzymatically active ubiquitin E3 ligase E6AP/UBE3A from mammalian cells

Protein Expression and Purification(2025)10.1016/j.pep.2025.106661

N/A

0.131DataRank · unranked

1 citations

Christine S. Muli, Rehab A Heikal, Marzena Dyba, Sergey G. Tarasov, Margaret M. Stratton +3 more

Discovery of a First‐in‐Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity

Angewandte Chemie International Edition(2025)10.1002/anie.202525126

N/A

0.112DataRank · unranked

1 citations

Frederick Nguele Meke, Zheng Zhang, Zhong‐Yin Zhang, Aaron D. Krabill, Christine S. Muli +12 more

Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.3c01661

N/A

0DataRank · unranked

12 citations

Rishi Patel, Muhammad Hassan Safdar, Hannah B. L. Jones, Adán Pinto-Fernández, Iolanda Vendrell +8 more

Natural product-inspired molecules for covalent inhibition of SHP2 tyrosine phosphatase

Tetrahedron(2024)10.1016/j.tet.2024.133918

N/A

0DataRank · unranked

9 citations

Aaron D. Krabill, Katelyn S. Gallagher, Christine S. Muli, Zihan Qu, Darci J. Trader +3 more

High-throughput assay exploiting disorder-to-order conformational switches: application to the proteasomal Rpn10:E6AP complex

Chemical Science(2024)10.1039/d3sc06370d

N/A

0DataRank · unranked

2 citations

Sergey G. Tarasov, Kylie J. Walters, Christine S. Muli

NMR in the Age of Modern Biomedical Research and Drug Discovery

Journal of Molecular Biology(2025)10.1016/j.jmb.2025.169302

N/A

0DataRank · unranked

3 citations

Wazo Myint, Christine S. Muli, Mioara Larion, Hiroshi Matsuo, Kylie J. Walters +1 more

Exploring the immunoproteasome's substrate preferences for improved hydrolysis and selectivity

RSC Chemical Biology(2025)10.1039/d5cb00114e

N/A

0DataRank · unranked

2 citations

Cody A. Loy, Darci J. Trader, Christine S. Muli

Discovery of a First‐in‐Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity

Angewandte Chemie(2025)10.1002/ange.202525126

N/A

0DataRank · unranked

0 citations

Frederick Nguele Meke, Zheng Zhang, Aaron D. Krabill, Christine S. Muli, Brenson A. Jassim +12 more

Discovery and Development of Cyclic Peptide Proteasome Stimulators

ChemBioChem(2023)10.1002/cbic.202300671

N/A

0DataRank · unranked

7 citations

Timothy Harris, Christine S. Muli, Marianne E. Maresh, Braden Baker, Chloe Smith +4 more

20S proteasome hydrolysis of LLVY substrates to determine preferences for moieties in its primed substrate channel

Bioorganic & Medicinal Chemistry Letters(2023)10.1016/j.bmcl.2023.129233

N/A

0DataRank · unranked

4 citations

Darci J. Trader, Christine S. Muli